Product analysis
Lithium Orotate 5 mg offers a simple, single-ingredient supplement with clearly disclosed content and favorable value.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
Lithium orotate is a favorable choice of lithium form. Its clear identification makes it easier to compare with other lithium preparations.
Ingredient Transparency100
The lithium amount and form are both clearly disclosed. That makes it straightforward to compare what each serving provides.
Value For Money80
The cost per serving offers favorable value. The single-ingredient format also makes the price easier to interpret.
Customer Satisfaction92
Customer ratings are strongly positive across a particularly large review pool. They show satisfaction without establishing effectiveness or safety.
Product Focus82
The single-ingredient approach appears well aligned with its intended goal. Its narrow scope keeps the combination simple.
- Format
Capsule - Container
- 60 VegCap(s)
- Per serving
- $0.15
- Also available
Lithium Orotate 5 mg$13.99- Customer rating
- 4.7 · 12,504 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Lithium (Lithium Orotate) | 5 mg |
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
Lithium Compound Optimization
Dose, Safety & Label Transparency100
Elemental Disclosure Precision
Dosage Appropriateness
Value80
Cost Per Serving Efficiency
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder.
- GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
- A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder.
- Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials.
- A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.